1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. HeiQ Plc
  6. News
  7. Summary
    AUCT   GB00BN2CJ299


Delayed London Stock Exchange  -  11:35 2022-07-01 am EDT
80.50 GBX    0.00%
06/22Renewcell and HeiQ Partner Up to Replace Polyester and Nylon with HeiQ AeoniQ Yarn Manufactured from Circulose Pulp
06/20HEIQ : and Renewcell Partner-Up to Replace Polyester and Nylon with HeiQ AeoniQ Yarn Manufactured from Circulose® Pulp
06/15Patagonia & HeiQ Plc Launch Jointly Developed Next Generation Mint-Based Textile Odor Control Technology
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PARTNER NEWS: Xefco® launches ground-breaking antiviral textile treatment in collaboration with Swiss antimicrobial textile leader HeiQ®

08/20/2021 | 10:04pm EDT

Content provided by PARTNER Xefco

XViroblock™antimicrobial copper treated textilesshown effective at inactivatingSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that has caused the COVID-19 pandemic, in as little as five minutes.

Australian-basedmaterials science and technology start-up, Xefco®,in collaboration with Swiss textile innovator HeiQ,has launched XViroblock™, the world's first thin-film antimicrobial copper surface treatment for textiles proven to exhibit significant viricidal activity against SARS-CoV-2 after only fiveminutes.

Studies conducted by the Peter Doherty Institute for Infection and Immunity(Doherty Institute) showed textiles finishedwith XViroblock inactivatedSARS-CoV-2, with significant inactivation occurring within fiveminutesof directcontact.

By developingtextile treatments that provide rapid viricidal and antibacterial functionality, Xefco hopes to reduce transmission of disease by reducing the persistence of pathogens on treated surfaces.

'The antimicrobial properties of copper are well-established. Our technology harnesses these incredible attributes through our unique process of applying an ultra-thin surface coating of the metal onto textiles,' said Tom Hussey, CEOand Co-Founder, Xefco.

'XViroblock can be applied to hydrophobic materials that are difficult to treat via conventional textile finishing methods. This unlocks new applications in personal protective equipment, medical textiles and air filtration aiding the defence against COVID-19. XViroblock may help reduce the transmission of infectious viruses particularly in applications where materials may not be replenished quickly or easily such as PPE used by front-line healthcare workers and air filters on planes and restaurants,' continued Mr. Hussey.

Researchers from the Doherty Institute exposed XViroblock treated textiles to known infectious concentrations of SARS-CoV-2 for incremental periods of time before extracting and measuring the remaining infectious virustitre. the testing proved a statistically significant reduction in infectious virus titre within5 minutesof exposure, compared to untreated textile.Further studies conducted also showed thatthetreated fabrics significantly degradedthe SARS-CoV-2 genomein a treatment concentration and time of exposure dependent maner.

Xefcospecializes in innovative thin-film coating technologies for the textile industry offered to outdoor apparel, fashion and home textile markets. At the onset of the pandemic, the business identified an opportunity to leverage its existing proprietary coating technologies and developed a process to apply a thin-filmsurface coating of copper onto textiles. The company has since shown efficacy of its technology against viruses including SARS-CoV-2, influenza A virus subtype H1N1,Human Coronavirus 229Eand also bacteria including Staphylococcus aureusand Klebsiella pneumoniae.

'Studying antiviral properties of materials and treatments like XViroblock is a key part of our ongoing research that aids the fight against COVID-19,' said Dr Julie McAuley, Senior Research Officer at the Doherty Institute.

'Our experimentation proves the XViroblock treated fabrics exhibit significant viricidal activity against SARS-CoV-2' Dr McAuley added.

'With XViroblock technology, we can now start to consider surgical masks and gloves as not only mechanical barriers, but as a tool to kill viruses and other infectious pathogens quickly where minutes actually count,' concluded Hussey.

XViroblock treated textiles have also been tested by an independent ISO 17025 accredited laboratory according to the ISO 18184 standard. Treated fabrics tested against influenza A virus subtype H1N1 and Human Coronavirus 229E showing a reduction of infectious virus present on the textiles of 99.95% and 99.9% respectively.

Xefco is collaboratingwith HeiQMaterials AG, Switzerland, a global leader in antimicrobial fabrics and textile chemicals to develop and manufacture XViroblock materials.Xefco has a long-standing collaborative history with HeiQand is preparing to manufacture materials for use in Face Masks, PPE and other otherprotective equipment.


HeiQ plc published this content on 21 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 August 2021 02:03:03 UTC.

© Publicnow 2021
All news about HEIQ PLC
06/22Renewcell and HeiQ Partner Up to Replace Polyester and Nylon with HeiQ AeoniQ Yarn Manu..
06/20HEIQ : and Renewcell Partner-Up to Replace Polyester and Nylon with HeiQ AeoniQ Yarn Manuf..
06/15Patagonia & HeiQ Plc Launch Jointly Developed Next Generation Mint-Based Textile Odor C..
04/28HeiQ Plc Reports Earnings Results for the Full Year Ended December 31, 2021
04/14HeiQ Plc Provides Earnings Guidance for the Fiscal Year Ended December 31, 2021
03/07Kamadgiri Fashion Forms New Subsidiary
02/14HeiQ Signs Partnership Agreement With Hugo Boss
02/14HEIQ : AeoniQ “game-changing” decarbonizing yarn endorsed by HUGO BOSS and The..
01/13HeiQ Plc Launches World's First Dual Action Textile Cooling Technology
01/13HEIQ : Launches World's First Dual Action Textile Cooling Technology
More news
Financials (USD)
Sales 2021 50,6 M - -
Net income 2021 - - -
Net cash 2021 17,9 M - -
P/E ratio 2021 57,5x
Yield 2021 -
Capitalization 131 M 130 M -
EV / Sales 2021 2,24x
EV / Sales 2022 1,68x
Nbr of Employees 221
Free-Float 64,1%
Duration : Period :
HeiQ Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HEIQ PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,81
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Carlo Centonze Chief Executive Officer & Executive Director
Esther Maria Dale Chairman
Xaver Hangartner Executive Director
Benjamin Scot Bergo Non-Executive Director
Karen Mary Brade Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
HEIQ PLC-12.02%131
ECOLAB INC.-34.46%43 922
SIKA AG-42.14%35 413
GIVAUDAN SA-29.95%32 417